ESC 365 - HFpEF and HFrEF display different anabolic phenotypes as assessed by IGF-1 and IGFBP-1

HFA Premium Access

HFpEF and HFrEF display different anabolic phenotypes as assessed by IGF-1 and IGFBP-1

Session: Directions in HFpEF research

Topic: HFpEF - Heart failure with preserved ejection fraction

Speaker: Doctor U. Ljung Faxen (Stockholm, SE)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Ulrika Ljung Faxen

Karolinska Institute, Stockholm (Sweden)

0 follower

4 more presentations in this session

HfpEF 2020: opportunities to intervene

Speaker: Professor R. De Boer (Rotterdam, NL)

Na+/Ca2+ Exchanger (NCX) inhibition with ORM 11035 improves cardiac function and remodeling without lowering blood pressure in a model of heart failure with preserved ejection fraction

Speaker: Professor F. Heinzel (Berlin, DE)

A restrictive pattern of LV filling is only present in one third of cardiac AL amyloidosis patients

Speaker: Associate Professor S. Perlini (Pavia, IT)

Dipeptidyl peptidase 4 inhibitor sitagliptin reduces oxidative stress, endothelial dysfunction and preserves diastolic function in a rat model of heart failure with preserved ejection fraction

Speaker: Doctor K. Urbanek (Naples, IT)

Access the full session

Directions in HFpEF research

Speakers: Doctor U. Ljung Faxen, Professor R. De Boer, Professor F. Heinzel, Associate Professor S. Perlini, Doctor K. Urbanek

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources